Sign in

CIK 0001855485 · <br>Emerging growth company

Calidi Biotherapeutics, Inc.

Sign in to watch
Tickers
CLDI CLDWW
Exchange
NYSE, OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
862967193
Phone
858-794-9600
Business address
4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CA, 92121
Former names
Calidi Biotherapeutics, Inc., First Light Acquisition Group, Inc.

Securities

  • CLDI Calidi Biotherapeutics, Inc. Common Stock NYSE
  • CLDWW Common stock OTC
  1. SC 13D Stake Beneficial Ownership Report
  2. 8-K Event Material agreement · New debt or obligation · Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
  3. 4 Derivatives Options or other derivatives
  4. 8-K Event Other events
  5. DEF 14A Proxy Proxy Statement
  6. UPLOAD Other SEC-generated Letter
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. UPLOAD Other SEC-generated Letter
  9. 10-Q Report Quarterly Report
  10. PRE 14A Proxy Proxy Statement (Preliminary)
  11. 10-Q Report Quarterly Report
  12. 10-K Report Annual Report
  13. SC 13G Stake Amended Statement of Ownership
  14. SC 13G Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G Stake Amended Statement of Ownership
  17. SC 13G Stake Amended Statement of Ownership
  18. SC 13G Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. 10-Q Report Quarterly Report

Page 19 of 21 · 406 filings